EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 8

Schisandra Schisandra chinensis (Turcz.) Baill.

Also called: wu wei zi, five-flavored fruit, omija

Schisandra is a climbing vine whose fruit, wu wei zi ("five-flavored fruit"), has a long history in traditional Chinese medicine as a tonic and for liver and stomach complaints. Supplements use fruit extracts; a related species, Schisandra sphenanthera, is also used.

Category
Botanical
Part used
Fruit
Strongest evidence
C Limited
Native range
Native from the Russian Far East to northern China and central Japan (POWO: "Russian Far East to N. China and Central Japan")
Reviewed
2026-10-29

Class 2 Moderately studied in people. This entry cites 3 RCTs of Schisandra chinensis extract alone versus placebo (sources [2], [3], [4]), 36 to 54 participants. The omija-soybean trial (source [5]) tested a mixture and is not counted. [2]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied4 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Schisandra does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Schisandra, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Muscle strength in adults over 50 doing low-intensity exerciseCA 12-week placebo-controlled trial in 54 adults (1 g extract daily) found greater knee-extensor strength gains; muscle mass, inflammatory and antioxidant markers did not differ. [2]
Quadriceps strength in postmenopausal womenCA 12-week placebo-controlled trial in 45 women (1,000 mg extract daily) reported increased quadriceps strength and lower resting lactate; other measures did not differ. [3]
Menopausal symptomsCIn a placebo-controlled trial (6 weeks of treatment, 12 weeks of follow-up; 36 women completed), Kupperman Index scores were lower with a Schisandra chinensis extract. [4]
Blood glucose in adults with mild hyperglycemia (omija and soybean mixture)CA 12-week placebo-controlled trial in 80 adults found lower fasting and post-meal glucose with an omija-soybean extract mixture; schisandra alone was not tested. [5]
Liver function measuresCSmall uncontrolled studies in liver transplant patients and chronic hepatitis suggested improved liver tests; MSK calls them inconclusive and notes schisandra can lower ALT and AST readings. [1]

Main constituents: Lignans, notably schisandrin A and schisantherins [1]; Polysaccharides; an anthocyanin identified as responsible for its antioxidant activity [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 1 g of extract per day for 12 weeks in a muscle-strength trial in adults over 50. [2]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    3 listed

    Tacrolimus; P-glycoprotein substrates; CYP1A2, CYP3A4 and CYP3A5 substrates

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    1 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • No serious side effects have been reported, but schisandra is not well studied in humans; in one small trial, sleepiness and cold extremities occurred in both treatment and placebo groups. [1]
  • No participant experienced adverse events in a 12-week trial of 1 g extract daily. [2]
  • Lab-test interaction: schisandra can reduce ALT and AST levels without changing bilirubin. [1]
Interactions

Interactions

Schisandra
From the table below 3 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of Schisandra
WithWhat happens
TacrolimusIn liver transplant patients, schisandra increased blood levels of tacrolimus. [1]
P-glycoprotein substratesLab and human studies suggest schisandra can inhibit P-glycoprotein and may interfere with the handling of certain drugs. [1]
CYP1A2, CYP3A4 and CYP3A5 substratesLignans inhibit CYP3A4/3A5 in vitro; animal studies suggest inhibition of CYP3A4 and 1A2, while long-term use can induce CYP3A4. Clinical relevance not yet determined. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • Health Canada's TCM ingredients monograph lists Schisandra chinensis fruit (wu wei zi) and Schisandra sphenanthera fruit (nan wu wei zi) as separate ingredients. [7]
Regulation

Regulatory status

  • US: FDA states that, by law, it does not approve dietary supplements before they are marketed; firms are responsible for the safety and labeling of their products. [8]
  • Canada: Schisandra chinensis fruit is listed in Health Canada's Traditional Chinese Medicine Ingredients monograph (May 29, 2026). [7]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Lignans (e.g., schisandrin A, schisantherins) Lignans [P3]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 1 entry naming schisandra: NDI 1319, submitted 2023-12-19 (schisandra fruit extract powder). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC classification of schisandra (Schisandra chinensis) was found in the IARC Monographs list of classifications (Volumes 1–142, list updated 2026-07-23; checked 2026-10-29). [P2]
  • No NTP technical report (2-year study) on schisandra (Schisandra chinensis) was found in NTP's list of technical reports (checked 2026-10-29). [P6]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • Tacrolimus: Increased tacrolimus blood levels in liver transplant patients. [P3]
  • P-glycoprotein substrates: Lab and human studies suggest P-glycoprotein inhibition. [P3]
  • CYP1A2, CYP3A4 and CYP3A5 substrates: Inhibition in vitro and in animals; long-term use can induce CYP3A4. Clinical relevance not yet determined. [P3]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) unless FDA grants an exemption petition under 111.75(a)(1)(ii) [P5]
  • Species identity (Schisandra chinensis versus S. sphenanthera fruit) — Health Canada lists the two species' fruits as distinct ingredients (wu wei zi and nan wu wei zi) [P4]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  3. Memorial Sloan Kettering Cancer Center. About Herbs: Schisandra (last updated June 3, 2022), 2022-06-03. mskcc.org
  4. Health Canada, NNHPD. Traditional Chinese Medicine Ingredients monograph (date May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
  5. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  6. National Toxicology Program. Technical Reports (list of TR studies; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources

Sources

  1. Memorial Sloan Kettering Cancer Center. About Herbs: Schisandra (last updated June 3, 2022), 2022-06-03. mskcc.org
  2. Cho YH, et al. Effect of Schisandra chinensis Baillon extracts and regular low-intensity exercise on muscle strength and mass in older adults: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2021;113(6):1440-1446 (PMID 33710261), 2021-06-01. pubmed.ncbi.nlm.nih.gov
  3. Park J, et al. Effect of Schisandra chinensis extract supplementation on quadriceps muscle strength and fatigue in adult women: a randomized, double-blind, placebo-controlled trial. Int J Environ Res Public Health 2020;17(7):2475 (PMID 32260466), 2020-04-04. pubmed.ncbi.nlm.nih.gov
  4. Park JY, Kim KH. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Climacteric 2016;19(6):574-580 (PMID 27763802), 2016-12. pubmed.ncbi.nlm.nih.gov
  5. Kim DS, et al. Efficacy and safety of Omija (Schisandra chinensis) extract mixture on the improvement of hyperglycemia: a randomized, double-blind, and placebo-controlled clinical trial. Nutrients 2022;14(15):3159 (PMID 35956334), 2022-07-30. pubmed.ncbi.nlm.nih.gov
  6. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Schisandra chinensis (Turcz.) Baill. (accessed 2026-10-29; native range: "Russian Far East to N. China and Central Japan"), 2026-10-29. powo.science.kew.org
  7. Health Canada, NNHPD. Traditional Chinese Medicine Ingredients monograph (date May 29, 2026), 2026-05-29. webprod.hc-sc.gc.ca
  8. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.